Sign In
6 Jan 2020 13:58
For immediate release | 6 January 2020 |
ALLIANCE PHARMA PLC
("Alliance" or the "Company")
Block Listing Six Monthly Return
Name of applicant: | ALLIANCE PHARMA PLC | |||
Names of schemes: | a) The Alliance Pharma plc Approved Share Option Plan 2005 b) The Alliance Pharma plc Share Option Plan 2006 c) The Alliance Pharma plc Company Share Option Plan 2015 | |||
Period of return: | From: | 28 June 2019 | To: | 28 December 2019 |
Number of securities originally admitted at date of admission: | 25,000,000 ordinary shares of 1p each 28 June 2017 | |||
Balance of unallotted securities under schemes from previous return: | a) 983,541 b) 15,345,688 a) 1,226,097 | |||
Plus: The amount by which the block schemes have been increased since the date of the last return (if any increase has been applied for): | a) Nil b) Nil c) Nil | |||
Less: Number of securities issued/allotted under schemes during period: | a) 434,467 b) 9,234,354 c) 588,621 | |||
Equals: Balance under schemes not yet issued/allotted at end of period: | a) 549,074 b) 6,111,334 c) 637,576 | |||
Name of contact: | Chris Chrysanthou, Company Secretary |
Telephone number of contact: | Tel. +44 (0)1249 705166 |
For further information:
Buchanan + 44 (0) 20 7466 5000
Mark Court / Hannah Ratcliff
Numis Securities Limited + 44 (0) 20 7260 1000
Nominated Adviser: Freddie Barnfield / Huw Jeremy
Corporate Broking: James Black
Investec Bank plc +44 (0) 20 7597 5970
Corporate Finance: Daniel Adams / Ed Thomas
Corporate Broking: Patrick Robb / Tejas Padalkar
Notes to editors:
About Alliance Pharma
Alliance, founded in 1998, is an international specialty pharmaceutical group based in Chippenham, Wiltshire, UK. The Group has sales in more than 100 countries worldwide via direct sales, joint ventures and a wide network of distributors. Alliance has a strong track record of acquiring the rights to established niche products and it currently owns or licenses the rights to approximately 90 pharmaceutical and consumer healthcare products. The Group continues to explore opportunities to expand its product portfolio.
Alliance joined the AIM market of the London Stock Exchange in December 2003 and trades under the symbol APH.
Follow the stocks
